Table of Contents Table of Contents
Previous Page  215 / 464 Next Page
Information
Show Menu
Previous Page 215 / 464 Next Page
Page Background

INTERDISCIPLINARY RADIOBIOLOGY CLINICAL BRACHYTHERAPY PHYSICS RTT YOUNG

215

Programme and Exhibition Guide |

POSTERS AND ELECTRONIC POSTERS

POSTERS

> MEK/ERK pathway sustains radioresistance of embryonal

rhabdomyosarcoma stem-like cell population.

F. Marampon (Italy), G. Gravina, C. Festuccia, C. Ciccarelli, F. De Felice,

D. Musio, V. Tombolini

PO-0980

> Disturbance of redox status enhances radiosensitivity of hepatocellular

carcinoma

H. Zhang (China), C. Sun

PO-0981

> Fused Toes Homolog (FTS) is a potential target for Notch-mediated

radioresistance in cervical cancer

W.Y. Park (Republic of Korea), P.D. Subramania, J.R. Yu

PO-0982

> Antrodia cinnamomea Regulates DNA Repair and Enhances

Radiosensitivity of Esophageal Cancer Cells

Y.M. Liu (Taiwan), Y.J. Chen, Y.K. Liu, T.H. Tsai

PO-0983

> Checkpoint HLA-G or its ligands ILT2/ILT4 changes radiosensitivity of

renal carcinoma cell lines

C. Hennequin

(France), M. Daouya, D. Tronik-Le Roux, J. LeMaoult,

N. Rouas-Freiss, F. Desgrandchamps, E. Carosella

PO-0984

> Tumor metabolic changes after neoadjuvant radiotherapy:

consequences for surgery-related metastases

N. Leroi (Belgium), F. Lallemand, J. Leenders, S. Blacher, P. De Tullio,

P. Coucke, A. Noel, P. Martinive

PO-0985

> Downregulation of the oncoprotein SET enhances RT-induced

apoptosis in hepatocellular carcinoma

C.Y. Huang (Taiwan), M.H. Hung, C.W. Kuo, C.T. Shih, M.H. Chen,

K.F. Chen

PO-0986

> Gemcitabine-based chemoradiotherapy gets improved with PARP

inhibitor in pancreatic cancer cells

W. Waissi (France), H. Burckel, E. Magisson, G. Larderet, G. Noel

PO-0987

> Following tumour microenvironment after Neoadjuvant radiotherapy

with IVIM perfusion analysis

F. Lallemand (Belgium), N. Leroi, M. Bahri, E. Balteau, A. Noël,

P. Coucke, A. Plenevaux, P. Martinive

PO-0988

> Sub-lethal radiation allows an efficient antitumor therapy with

engineered T-cells in RIP-Tag2 mice